206 related articles for article (PubMed ID: 30898625)
1. Disappearance of a myoma after pregnancy in a 38 years old patient, treated by ulipristal acetate without success before getting pregnant.
Pécout M; Cosson M; Collinet P; Rubod C; Giraudet G
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):781-783. PubMed ID: 30898625
[TBL] [Abstract][Full Text] [Related]
2. Uterine fibroid management: from the present to the future.
Donnez J; Dolmans MM
Hum Reprod Update; 2016 Nov; 22(6):665-686. PubMed ID: 27466209
[TBL] [Abstract][Full Text] [Related]
3. Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?
Pourcelot AG; Capmas P; Fernandez H
J Gynecol Obstet Hum Reprod; 2017 Mar; 46(3):249-254. PubMed ID: 28403922
[TBL] [Abstract][Full Text] [Related]
4. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
5. Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial.
de Milliano I; Huirne JAF; Thurkow AL; Radder C; Bongers MY; van Vliet H; van de Lande J; van de Ven PM; Hehenkamp WJK
Acta Obstet Gynecol Scand; 2020 Jan; 99(1):89-98. PubMed ID: 31468503
[TBL] [Abstract][Full Text] [Related]
6. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
7. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
Szamatowicz M; Kotarski J
Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
[TBL] [Abstract][Full Text] [Related]
8. Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids.
Strand T; Kives S; Leyland N; Ashkenas J; Janiszewski P; Thiel J
J Obstet Gynaecol Can; 2020 Dec; 42(12):1475-1482.e2. PubMed ID: 33046429
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy.
Ferrero S; Scala C; Vellone VG; Paudice M; Vitale SG; Cianci A; Barra F
Gynecol Obstet Invest; 2020; 85(2):178-183. PubMed ID: 31940645
[TBL] [Abstract][Full Text] [Related]
10. [LAPAROSCOPIC MYOMECTOMY AFTER ULIPRISTAL ACFTATF TRFATMFMT.].
Blagovest B; Magunska N
Akush Ginekol (Sofiia); 2016; 55(5):29-31. PubMed ID: 29790712
[TBL] [Abstract][Full Text] [Related]
11. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
[TBL] [Abstract][Full Text] [Related]
12. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids.
Ferrero S; Vellone VG; Barra F
Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):107-116. PubMed ID: 29250979
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
15. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
16. Ulipristal acetate for uterine fibroid-related symptoms.
Puchar A; Luton D; Koskas M
Drugs Today (Barc); 2015 Nov; 51(11):661-7. PubMed ID: 26744741
[TBL] [Abstract][Full Text] [Related]
17. Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy.
Brun JL; Rajaonarison J; Froeliger A; Monseau-Thiburce AC; Randriamboavonjy R; Vogler A
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():13-18. PubMed ID: 29328939
[TBL] [Abstract][Full Text] [Related]
18. Use of Ulipristal Acetate for the Management of Fibroid-Related Acute Abnormal Uterine Bleeding.
Arendas K; Leyland NA
J Obstet Gynaecol Can; 2016 Jan; 38(1):80-3. PubMed ID: 26872761
[TBL] [Abstract][Full Text] [Related]
19. Fibroid management in premenopausal women.
Donnez J; Courtoy GE; Dolmans MM
Climacteric; 2019 Feb; 22(1):27-33. PubMed ID: 30601065
[TBL] [Abstract][Full Text] [Related]
20. Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in France.
Fernandez H; Jourdain O; Villefranque V; Lehmann M; Lafuma A; Trancart M
BMJ Open; 2017 Sep; 7(9):e015571. PubMed ID: 28871011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]